Physician profile
Stephanie Strobl
NPI 1275961823
$15,610.00
in general payments reported to CMS, 2019-2025
26 companies · $5,227 in 2025
The $5,227 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,119 · 2022: $2,780 · 2023: $3,288 · 2024: $1,197 · 2025: $5,227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,629 · Honoraria: $2,567 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,805 · Travel and Lodging: $1,111 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,628.66 |
| Honoraria | $2,566.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,805.00 |
| Travel and Lodging | $1,110.89 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $6,684.34 | 2021-2023 | Onli, Vapro Plus Pocket, Infyna Chic |
| Ferring Pharmaceuticals INC. | $4,282.59 | 2024-2025 | Adstiladrin, Menopur |
| Medtronic, INC. | $1,973.92 | 2021-2025 | Interstim, Altaviva |
| Sumitomo Pharma America, INC. | $564.31 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $560.62 | 2021-2024 | Urolift |
| Janssen Biotech, INC. | $226.88 | 2021-2025 | Erleada |
| Abbvie INC. | $179.89 | 2022-2025 | |
| Antares Pharma, INC. | $176.41 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Coloplast Corp | $123.15 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $118.74 | 2021-2024 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $118.63 | 2023-2025 | Keytruda, Welireg, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $73.13 | 2022-2023 | |
| Dendreon Pharmaceuticals LLC | $72.72 | 2021-2024 | Provenge |
| Procept Biorobotics Corporation | $65.16 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Urovant Sciences INC | $52.44 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $52.05 | 2024-2025 | Eligard |
| Endo USA, INC. | $45.77 | 2024 | Xiaflex |
| Novartis Pharmaceuticals Corporation | $39.52 | 2021-2025 | |
| Blue Earth Diagnostics | $38.32 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $36.66 | 2025 | Lynparza |
| Accord Healthcare, INC. | $33.51 | 2024-2025 | |
| 180 Medical, INC. | $28.77 | 2022 | |
| Sun Pharmaceutical Industries INC. | $19.31 | 2022 | |
| Myovant Sciences INC. | $16.95 | 2022 | |
| Progenics Pharmaceuticals, INC. | $14.05 | 2022 | |
| Convatec INC. | $12.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Strobl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.